Minhang Xin

2.1k total citations · 1 hit paper
71 papers, 1.8k citations indexed

About

Minhang Xin is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, Minhang Xin has authored 71 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 23 papers in Organic Chemistry and 21 papers in Genetics. Recurrent topics in Minhang Xin's work include PI3K/AKT/mTOR signaling in cancer (22 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Quinazolinone synthesis and applications (14 papers). Minhang Xin is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (22 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Quinazolinone synthesis and applications (14 papers). Minhang Xin collaborates with scholars based in China, United States and India. Minhang Xin's co-authors include San‐Qi Zhang, Hongyi Zhao, Shuai Mao, Chengyuan Liang, Hao Zhang, Suresh Thareja, Junjie Zhang, Feng Tang, Weiming Duan and Jiajia Sun and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Organic Letters.

In The Last Decade

Minhang Xin

70 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Small molecule selenium-containing compounds: Recent development and therapeutic applications

2021 179 citations San‐Qi Zhang, Jiyu Li et al. European Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Minhang Xin China	22	1.0k	582	427	291	183	71	1.8k
Jinyun Dong China	24	1.1k 1.0×	479 0.8×	733 1.7×	182 0.6×	136 0.7×	65	2.1k
Linjiang Tong China	30	1.5k 1.4×	689 1.2×	604 1.4×	100 0.3×	113 0.6×	99	2.3k
San‐Qi Zhang China	25	1000 1.0×	776 1.3×	356 0.8×	92 0.3×	118 0.6×	100	1.8k
Anna Kruczynski France	26	1.3k 1.3×	313 0.5×	779 1.8×	96 0.3×	110 0.6×	71	2.1k
Jinlei Bian China	26	1.1k 1.0×	441 0.8×	392 0.9×	57 0.2×	85 0.5×	98	1.9k
Kevin Kish United States	20	930 0.9×	381 0.7×	265 0.6×	295 1.0×	433 2.4×	38	2.0k
Elaine Willmore United Kingdom	23	1.4k 1.3×	208 0.4×	778 1.8×	129 0.4×	84 0.5×	54	1.7k
Hong Ding China	26	1.7k 1.7×	311 0.5×	349 0.8×	52 0.2×	98 0.5×	80	2.3k
Ramesh Ummanni India	25	756 0.7×	494 0.8×	167 0.4×	92 0.3×	68 0.4×	64	1.6k
Donghwa Kim South Korea	19	764 0.7×	140 0.2×	313 0.7×	80 0.3×	119 0.7×	42	1.3k

Countries citing papers authored by Minhang Xin

Since Specialization

Citations

This map shows the geographic impact of Minhang Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minhang Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minhang Xin more than expected).

Fields of papers citing papers by Minhang Xin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minhang Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minhang Xin. The network helps show where Minhang Xin may publish in the future.

Co-authorship network of co-authors of Minhang Xin

This figure shows the co-authorship network connecting the top 25 collaborators of Minhang Xin. A scholar is included among the top collaborators of Minhang Xin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minhang Xin. Minhang Xin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yuan, Bo, Mengyan Ma, Yujie Wu, et al.. (2025). Discovery of novel covalent PI3Kδ inhibitors bearing alaninamide moiety by lysine-targeted covalent strategy. European Journal of Medicinal Chemistry. 297. 117948–117948. 1 indexed citations

Wang, Fang, et al.. (2024). Menin-MLL protein–protein interaction inhibitors: a patent review (2021-present). Expert Opinion on Therapeutic Patents. 35(1). 65–78. 1 indexed citations

Gao, Li, Mengyan Ma, San‐Qi Zhang, et al.. (2023). Design, synthesis and bioactivity evaluation of selenium-containing PI3Kδ inhibitors. Bioorganic Chemistry. 140. 106815–106815. 3 indexed citations

Zhao, Hongyi, Minhang Xin, & San‐Qi Zhang. (2023). Progress of small molecules for targeted protein degradation: PROTACs and other technologies. Drug Development Research. 84(2). 337–394. 19 indexed citations

Zhang, San‐Qi, et al.. (2021). Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia. Journal of Medicinal Chemistry. 64(21). 15519–15533. 14 indexed citations

Zhao, Hongyi, Xueyan Yang, Shemin Lu, et al.. (2020). Discovery of potent small molecule PROTACs targeting mutant EGFR. European Journal of Medicinal Chemistry. 208. 112781–112781. 75 indexed citations

Wang, Yazhou, Wei Huang, Minhang Xin, et al.. (2019). Discovery of potent anti-inflammatory 4-(4,5,6,7-tetrahydrofuro[3,2-c]pyridin-2-yl) pyrimidin-2-amines for use as Janus kinase inhibitors. Bioorganic & Medicinal Chemistry. 27(12). 2592–2597. 8 indexed citations

Zhang, San‐Qi, Yifan Feng, Jin Wang, et al.. (2019). Alkylsulfonamide-containing quinazoline derivatives as potent and orally bioavailable PI3Ks inhibitors. Bioorganic & Medicinal Chemistry. 27(20). 114930–114930. 15 indexed citations

Lei, Hao, Hao Zhang, Yanjie Liu, et al.. (2019). Discovery of novel 9-heterocyclyl substituted 9H-purines as L858R/T790M/C797S mutant EGFR tyrosine kinase inhibitors. European Journal of Medicinal Chemistry. 186. 111888–111888. 54 indexed citations

10.

Liang, Chengyuan, et al.. (2018). The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review. European Journal of Medicinal Chemistry. 151. 315–326. 137 indexed citations

11.

Zhang, Hao, Hongyi Zhao, Xueyan Yang, et al.. (2018). Synthesis and biological evaluation of irreversible EGFR tyrosine kinase inhibitors containing pyrido[3,4-d]pyrimidine scaffold. Bioorganic & Medicinal Chemistry. 26(12). 3619–3633. 18 indexed citations

12.

Wang, Huiyan, et al.. (2017). Discovery of 2-(pyridin-2-yl)aniline as a directing group for the sp² C–H bond amination mediated by cupric acetate. Organic & Biomolecular Chemistry. 15(31). 6622–6631. 12 indexed citations

13.

Xin, Minhang, Jun Wen, Han Shen, et al.. (2016). Synthesis and pharmacological evaluation of trifluoromethyl containing 4-(2-pyrimidinylamino)benzamides as Hedgehog signaling pathway inhibitors. Bioorganic & Medicinal Chemistry. 24(5). 1079–1088. 9 indexed citations

14.

Xin, Minhang, et al.. (2016). Discovery of novel 4-(2-pyrimidinylamino)benzamide derivatives as highly potent and orally available hedgehog signaling pathway inhibitors. European Journal of Medicinal Chemistry. 110. 115–125. 10 indexed citations

15.

Zhang, Hao, et al.. (2015). Synthesis and antitumor activity evaluation of PI3K inhibitors containing 3-substituted quinazolin-4(3H)-one moiety. Bioorganic & Medicinal Chemistry. 23(24). 7765–7776. 22 indexed citations

16.

Xin, Minhang, et al.. (2015). Synthesis and antitumor activities evaluation of m-(4-morpholinoquinazolin-2-yl)benzamides in vitro and in vivo. European Journal of Medicinal Chemistry. 96. 382–395. 32 indexed citations

17.

Xin, Minhang, Wei Huang, Jin Qiu, et al.. (2015). Synthesis and biological evaluation of novel 7-substituted 3-(4-phenoxyphenyl)thieno[3,2-c]pyridin-4-amines as potent Bruton’s tyrosine kinase (BTK) inhibitors. Bioorganic & Medicinal Chemistry. 23(19). 6250–6257. 10 indexed citations

18.

Xin, Minhang. (2015). Hedgehog inhibitors: a patent review (2013 – present). Expert Opinion on Therapeutic Patents. 25(5). 549–565. 26 indexed citations

19.

Wang, Xiaomeng, Shuai Mao, Lei Cao, et al.. (2015). Modification of N-(6-(2-methoxy-3-(4-fluorophenylsulfonamido)pyridin-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)acetamide as PI3Ks inhibitor by replacement of the acetamide group with alkylurea. Bioorganic & Medicinal Chemistry. 23(17). 5662–5671. 14 indexed citations

20.

Xin, Minhang, Jun Wen, Feng Tang, et al.. (2013). Synthesis and evaluation of 4-(2-pyrimidinylamino) benzamides inhibitors of hedgehog signaling pathway. Bioorganic & Medicinal Chemistry Letters. 24(3). 983–988. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact